PATENT CLAIM ANALYSIS

Application Number: 16022577
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["424", "093400"]

Abstract:
The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract.

Claim (Index 14):
The composition of  claim 1 , wherein the composition comprises a bacterial strain of the species  Blautia hydrogenotrophica , for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract in a subject diagnosed with IBS.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 94.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15916205', '15915885', '16022207', '15915889', '16022256']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8079763876791104
- 35 USC 102 Novelty (BERT): 0.6783896914234964
- Combined Prediction Score: 0.795017718053549
- Mean Citation Score: 680.5063899999999
- Max Citation Score: 775.2112
- Similarity Product: 561.9315213429451

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test